Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Urbaniak AM"'
Publikováno v:
Biochemical and Biophysical Research Communications
Tumour necrosis factor (TNF) is produced by primary human macrophages in response to stimulation by exogenous pathogen-associated molecular patterns (PAMPs) and endogenous damage-associated molecular patterns (DAMPs) via Toll-like receptor (TLR) sign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::05cc0366fa7ebb6e4c28444b2d5f8d06
http://hdl.handle.net/10044/1/58435
http://hdl.handle.net/10044/1/58435
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Page TH; Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Roosevelt Drive, Oxford, OX3 7FY, United Kingdom., Urbaniak AM; Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Roosevelt Drive, Oxford, OX3 7FY, United Kingdom., Espirito Santo AI; Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Roosevelt Drive, Oxford, OX3 7FY, United Kingdom., Danks L; Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Roosevelt Drive, Oxford, OX3 7FY, United Kingdom., Smallie T; Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Roosevelt Drive, Oxford, OX3 7FY, United Kingdom., Williams LM; Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Roosevelt Drive, Oxford, OX3 7FY, United Kingdom., Horwood NJ; Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Roosevelt Drive, Oxford, OX3 7FY, United Kingdom. Electronic address: nicole.horwood@kennedy.ox.ac.uk.
Publikováno v:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2018 May 05; Vol. 499 (2), pp. 260-266. Date of Electronic Publication: 2018 Mar 22.
Autor:
Urbaniak AM; HTA and Reimbursement Unit, The Norwegian Medicines Agency (NOMA), Strømsveien 96, 0663, Oslo, Norway. anna.m.urbaniak@gmail.com.; Department of Economics, School of Arts and Social Sciences, University of London, London, UK. anna.m.urbaniak@gmail.com., Strøm BO; HTA and Reimbursement Unit, The Norwegian Medicines Agency (NOMA), Strømsveien 96, 0663, Oslo, Norway., Krontveit R; HTA and Reimbursement Unit, The Norwegian Medicines Agency (NOMA), Strømsveien 96, 0663, Oslo, Norway., Svanqvist KH; HTA and Reimbursement Unit, The Norwegian Medicines Agency (NOMA), Strømsveien 96, 0663, Oslo, Norway.
Publikováno v:
Drugs & aging [Drugs Aging] 2017 Aug; Vol. 34 (8), pp. 635-645.
Autor:
Schoenherr N; Boehringer Ingelheim, Bracknell, UK., Watkins M; Boehringer Ingelheim, Bracknell, UK., Urbaniak AM; Boehringer Ingelheim, Bracknell, UK.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2014 Nov; Vol. 17 (7), pp. A657. Date of Electronic Publication: 2014 Oct 26.
Autor:
Horwood NJ; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, University of Oxford, London, UK. nicole.horwood@kennedy.ox.ac.uk, Urbaniak AM, Danks L
Publikováno v:
International reviews of immunology [Int Rev Immunol] 2012 Apr; Vol. 31 (2), pp. 87-103.
Autor:
Smolinska MJ; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, Oxford University, London W6 8LH, United Kingdom., Page TH, Urbaniak AM, Mutch BE, Horwood NJ
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2011 Dec 01; Vol. 187 (11), pp. 6043-51. Date of Electronic Publication: 2011 Oct 21.
Autor:
Page TH; Kennedy Institute of Rheumatology, Imperial College of Science, Technology and Medicine, 65 Aspenlea Road, London W6 8LH, UK., Smolinska M, Gillespie J, Urbaniak AM, Foxwell BM
Publikováno v:
Current molecular medicine [Curr Mol Med] 2009 Feb; Vol. 9 (1), pp. 69-85.